Targeted Precision, Complex Promise
Antibody-drug conjugates (ADCs) have evolved from an elegant scientific concept into one of oncology’s most dynamic therapeutic classes. By fusing the targeting specificity of monoclonal antibodies with the cell-killing power of highly […]
The post Targeted Precision, Complex Promise appeared first on GEN - Genetic Engineering and Biotechnology News.
